Skip to main content
NCBI home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1992 May 1;175(5):1195–1205. doi: 10.1084/jem.175.5.1195

Transferrin receptor mediates uptake and presentation of hepatitis B envelope antigen by T lymphocytes

PMCID: PMC2119224  PMID: 1569393

Abstract

Human activated T lymphocytes expressing class II molecules are able to present only complex antigens that bind to their own surface receptors, and thus can be captured, internalized, and processed through the class II major histocompatibility complex processing pathway. We have used the antigen-presenting T cell system to identify the viral receptor used by hepatitis B virus (HBV) to enter cells, as well as the sequence of HB envelope antigen (HBenvAg) involved in this interaction. Results show that both CD4+ and CD8+ T clones can process and present HBenvAg to class II-restricted cytotoxic T lymphocytes and that the CD71 transferrin receptor (TfR) is involved in efficient HBenvAg uptake by T cells. Moreover, we provide evidence that the HBenvAg sequence interacting with the T cell surface is contained within the pre-S2 region. Since TfR is also expressed on hepatocytes, it might represent a portal of cellular entry for HBV infection. This system of antigen presentation by T cells may serve as a model to study both lymphocyte receptors used by lymphocytotropic viruses and viral proteins critical to bind them.

Full Text

The Full Text of this article is available as a PDF (993.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alberti A., Gerlich W. H., Heermann K. H., Pontisso P. Nature and display of hepatitis B virus envelope proteins and the humoral immune response. Springer Semin Immunopathol. 1990;12(1):5–23. doi: 10.1007/BF00192678. [DOI] [PubMed] [Google Scholar]
  2. Antigen processing. Immunol Rev. 1988 Dec;106:1–222. [PubMed] [Google Scholar]
  3. Baird A., Florkiewicz R. Z., Maher P. A., Kaner R. J., Hajjar D. P. Mediation of virion penetration into vascular cells by association of basic fibroblast growth factor with herpes simplex virus type 1. Nature. 1990 Nov 22;348(6299):344–346. doi: 10.1038/348344a0. [DOI] [PubMed] [Google Scholar]
  4. Barnaba V., Franco A., Alberti A., Balsano C., Benvenuto R., Balsano F. Recognition of hepatitis B virus envelope proteins by liver-infiltrating T lymphocytes in chronic HBV infection. J Immunol. 1989 Oct 15;143(8):2650–2655. [PubMed] [Google Scholar]
  5. Barnaba V., Franco A., Alberti A., Benvenuto R., Balsano F. Selective killing of hepatitis B envelope antigen-specific B cells by class I-restricted, exogenous antigen-specific T lymphocytes. Nature. 1990 May 17;345(6272):258–260. doi: 10.1038/345258a0. [DOI] [PubMed] [Google Scholar]
  6. Brodsky F. M., Guagliardi L. E. The cell biology of antigen processing and presentation. Annu Rev Immunol. 1991;9:707–744. doi: 10.1146/annurev.iy.09.040191.003423. [DOI] [PubMed] [Google Scholar]
  7. Buus S., Sette A., Colon S. M., Miles C., Grey H. M. The relation between major histocompatibility complex (MHC) restriction and the capacity of Ia to bind immunogenic peptides. Science. 1987 Mar 13;235(4794):1353–1358. doi: 10.1126/science.2435001. [DOI] [PubMed] [Google Scholar]
  8. Celis E., Ou D., Otvos L., Jr Recognition of hepatitis B surface antigen by human T lymphocytes. Proliferative and cytotoxic responses to a major antigenic determinant defined by synthetic peptides. J Immunol. 1988 Mar 15;140(6):1808–1815. [PubMed] [Google Scholar]
  9. Chesnut R. W., Grey H. M. Antigen presentation by B cells and its significance in T-B interactions. Adv Immunol. 1986;39:51–94. doi: 10.1016/s0065-2776(08)60348-x. [DOI] [PubMed] [Google Scholar]
  10. Co M. S., Gaulton G. N., Fields B. N., Greene M. I. Isolation and biochemical characterization of the mammalian reovirus type 3 cell-surface receptor. Proc Natl Acad Sci U S A. 1985 Mar;82(5):1494–1498. doi: 10.1073/pnas.82.5.1494. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Duke R. C. Self recognition by T cells. I. Bystander killing of target cells bearing syngeneic MHC antigens. J Exp Med. 1989 Jul 1;170(1):59–71. doi: 10.1084/jem.170.1.59. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Eppstein D. A., Marsh Y. V., Schreiber A. B., Newman S. R., Todaro G. J., Nestor J. J., Jr Epidermal growth factor receptor occupancy inhibits vaccinia virus infection. Nature. 1985 Dec 19;318(6047):663–665. doi: 10.1038/318663a0. [DOI] [PubMed] [Google Scholar]
  13. Esserman L., Takahashi S., Rojas V., Warnke R., Levy R. An epitope of the transferrin receptor is exposed on the cell surface of high-grade but not low-grade human lymphomas. Blood. 1989 Dec;74(8):2718–2729. [PubMed] [Google Scholar]
  14. Ezekowitz R. A., Williams D. J., Koziel H., Armstrong M. Y., Warner A., Richards F. F., Rose R. M. Uptake of Pneumocystis carinii mediated by the macrophage mannose receptor. Nature. 1991 May 9;351(6322):155–158. doi: 10.1038/351155a0. [DOI] [PubMed] [Google Scholar]
  15. Fingeroth J. D., Weis J. J., Tedder T. F., Strominger J. L., Biro P. A., Fearon D. T. Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2. Proc Natl Acad Sci U S A. 1984 Jul;81(14):4510–4514. doi: 10.1073/pnas.81.14.4510. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Ganem D., Varmus H. E. The molecular biology of the hepatitis B viruses. Annu Rev Biochem. 1987;56:651–693. doi: 10.1146/annurev.bi.56.070187.003251. [DOI] [PubMed] [Google Scholar]
  17. Germain R. N. Antigen processing and CD4+ T cell depletion in AIDS. Cell. 1988 Aug 12;54(4):441–444. doi: 10.1016/0092-8674(88)90062-1. [DOI] [PubMed] [Google Scholar]
  18. Gerrard T. L., Volkman D. J., Jurgensen C. H., Fauci A. S. Activated human T cells can present denatured antigen. Hum Immunol. 1986 Dec;17(4):416–425. doi: 10.1016/0198-8859(86)90301-0. [DOI] [PubMed] [Google Scholar]
  19. Hirata T., Bitterman P. B., Mornex J. F., Crystal R. G. Expression of the transferrin receptor gene during the process of mononuclear phagocyte maturation. J Immunol. 1986 Feb 15;136(4):1339–1345. [PubMed] [Google Scholar]
  20. Itoh Y., Takai E., Ohnuma H., Kitajima K., Tsuda F., Machida A., Mishiro S., Nakamura T., Miyakawa Y., Mayumi M. A synthetic peptide vaccine involving the product of the pre-S(2) region of hepatitis B virus DNA: protective efficacy in chimpanzees. Proc Natl Acad Sci U S A. 1986 Dec;83(23):9174–9178. doi: 10.1073/pnas.83.23.9174. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Jacobson S., Richert J. R., Biddison W. E., Satinsky A., Hartzman R. J., McFarland H. F. Measles virus-specific T4+ human cytotoxic T cell clones are restricted by class II HLA antigens. J Immunol. 1984 Aug;133(2):754–757. [PubMed] [Google Scholar]
  22. Jing S. Q., Spencer T., Miller K., Hopkins C., Trowbridge I. S. Role of the human transferrin receptor cytoplasmic domain in endocytosis: localization of a specific signal sequence for internalization. J Cell Biol. 1990 Feb;110(2):283–294. doi: 10.1083/jcb.110.2.283. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Körner H., Schliephake A., Winter J., Zimprich F., Lassmann H., Sedgwick J., Siddell S., Wege H. Nucleocapsid or spike protein-specific CD4+ T lymphocytes protect against coronavirus-induced encephalomyelitis in the absence of CD8+ T cells. J Immunol. 1991 Oct 1;147(7):2317–2323. [PubMed] [Google Scholar]
  24. LaSalle J. M., Ota K., Hafler D. A. Presentation of autoantigen by human T cells. J Immunol. 1991 Aug 1;147(3):774–780. [PubMed] [Google Scholar]
  25. Lanzavecchia A., Abrignani S., Scheidegger D., Obrist R., Dörken B., Moldenhauer G. Antibodies as antigens. The use of mouse monoclonal antibodies to focus human T cells against selected targets. J Exp Med. 1988 Feb 1;167(2):345–352. doi: 10.1084/jem.167.2.345. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Lanzavecchia A. Antigen-specific interaction between T and B cells. Nature. 1985 Apr 11;314(6011):537–539. doi: 10.1038/314537a0. [DOI] [PubMed] [Google Scholar]
  27. Lanzavecchia A. Is suppression a function of class II--restricted cytotoxic T cells? Immunol Today. 1989 May;10(5):157–159. doi: 10.1016/0167-5699(89)90172-2. [DOI] [PubMed] [Google Scholar]
  28. Lanzavecchia A. Receptor-mediated antigen uptake and its effect on antigen presentation to class II-restricted T lymphocytes. Annu Rev Immunol. 1990;8:773–793. doi: 10.1146/annurev.iy.08.040190.004013. [DOI] [PubMed] [Google Scholar]
  29. Lanzavecchia A., Roosnek E., Gregory T., Berman P., Abrignani S. T cells can present antigens such as HIV gp120 targeted to their own surface molecules. Nature. 1988 Aug 11;334(6182):530–532. doi: 10.1038/334530a0. [DOI] [PubMed] [Google Scholar]
  30. Lasky L. A., Nakamura G., Smith D. H., Fennie C., Shimasaki C., Patzer E., Berman P., Gregory T., Capon D. J. Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptor. Cell. 1987 Sep 11;50(6):975–985. doi: 10.1016/0092-8674(87)90524-1. [DOI] [PubMed] [Google Scholar]
  31. Lentz T. L., Burrage T. G., Smith A. L., Crick J., Tignor G. H. Is the acetylcholine receptor a rabies virus receptor? Science. 1982 Jan 8;215(4529):182–184. doi: 10.1126/science.7053569. [DOI] [PubMed] [Google Scholar]
  32. Michel M. L., Pontisso P., Sobczak E., Malpièce Y., Streeck R. E., Tiollais P. Synthesis in animal cells of hepatitis B surface antigen particles carrying a receptor for polymerized human serum albumin. Proc Natl Acad Sci U S A. 1984 Dec;81(24):7708–7712. doi: 10.1073/pnas.81.24.7708. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Milich D. R. Genetic and molecular basis for T- and B-cell recognition of hepatitis B viral antigens. Immunol Rev. 1987 Oct;99:71–103. doi: 10.1111/j.1600-065x.1987.tb01173.x. [DOI] [PubMed] [Google Scholar]
  34. Neckers L. M., Cossman J. Transferrin receptor induction in mitogen-stimulated human T lymphocytes is required for DNA synthesis and cell division and is regulated by interleukin 2. Proc Natl Acad Sci U S A. 1983 Jun;80(11):3494–3498. doi: 10.1073/pnas.80.11.3494. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Oldstone M. B. Viral persistence. Cell. 1989 Feb 24;56(4):517–520. doi: 10.1016/0092-8674(89)90573-4. [DOI] [PubMed] [Google Scholar]
  36. Ottenhoff T. H., Mutis T. Specific killing of cytotoxic T cells and antigen-presenting cells by CD4+ cytotoxic T cell clones. A novel potentially immunoregulatory T-T cell interaction in man. J Exp Med. 1990 Jun 1;171(6):2011–2024. doi: 10.1084/jem.171.6.2011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Pelosi E., Testa U., Louache F., Thomopoulos P., Salvo G., Samoggia P., Peschle C. Expression of transferrin receptors in phytohemagglutinin-stimulated human T-lymphocytes. Evidence for a three-step model. J Biol Chem. 1986 Mar 5;261(7):3036–3042. [PubMed] [Google Scholar]
  38. Rock K. L., Benacerraf B., Abbas A. K. Antigen presentation by hapten-specific B lymphocytes. I. Role of surface immunoglobulin receptors. J Exp Med. 1984 Oct 1;160(4):1102–1113. doi: 10.1084/jem.160.4.1102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Romet-Lemonne J. L., McLane M. F., Elfassi E., Haseltine W. A., Azocar J., Essex M. Hepatitis B virus infection in cultured human lymphoblastoid cells. Science. 1983 Aug 12;221(4611):667–669. doi: 10.1126/science.6867736. [DOI] [PubMed] [Google Scholar]
  40. Siliciano R. F., Lawton T., Knall C., Karr R. W., Berman P., Gregory T., Reinherz E. L. Analysis of host-virus interactions in AIDS with anti-gp120 T cell clones: effect of HIV sequence variation and a mechanism for CD4+ cell depletion. Cell. 1988 Aug 12;54(4):561–575. doi: 10.1016/0092-8674(88)90078-5. [DOI] [PubMed] [Google Scholar]
  41. Springer T. A. Adhesion receptors of the immune system. Nature. 1990 Aug 2;346(6283):425–434. doi: 10.1038/346425a0. [DOI] [PubMed] [Google Scholar]
  42. Staunton D. E., Merluzzi V. J., Rothlein R., Barton R., Marlin S. D., Springer T. A. A cell adhesion molecule, ICAM-1, is the major surface receptor for rhinoviruses. Cell. 1989 Mar 10;56(5):849–853. doi: 10.1016/0092-8674(89)90689-2. [DOI] [PubMed] [Google Scholar]
  43. Testa U., Petrini M., Quaranta M. T., Pelosi-Testa E., Mastroberardino G., Camagna A., Boccoli G., Sargiacomo M., Isacchi G., Cozzi A. Iron up-modulates the expression of transferrin receptors during monocyte-macrophage maturation. J Biol Chem. 1989 Aug 5;264(22):13181–13187. [PubMed] [Google Scholar]
  44. Testa U., Thomopoulos P., Vinci G., Titeux M., Bettaieb A., Vainchenker W., Rochant H. Transferrin binding to K562 cell line. Effect of heme and sodium butyrate induction. Exp Cell Res. 1982 Aug;140(2):251–260. doi: 10.1016/0014-4827(82)90112-4. [DOI] [PubMed] [Google Scholar]
  45. Testa U. Transferrin receptors: structure and function. Curr Top Hematol. 1985;5:127–161. [PubMed] [Google Scholar]
  46. Trowbridge I. S., Omary M. B. Human cell surface glycoprotein related to cell proliferation is the receptor for transferrin. Proc Natl Acad Sci U S A. 1981 May;78(5):3039–3043. doi: 10.1073/pnas.78.5.3039. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Unanue E. R. Antigen-presenting function of the macrophage. Annu Rev Immunol. 1984;2:395–428. doi: 10.1146/annurev.iy.02.040184.002143. [DOI] [PubMed] [Google Scholar]
  48. Weissman A. M., Klausner R. D., Rao K., Harford J. B. Exposure of K562 cells to anti-receptor monoclonal antibody OKT9 results in rapid redistribution and enhanced degradation of the transferrin receptor. J Cell Biol. 1986 Mar;102(3):951–958. doi: 10.1083/jcb.102.3.951. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Yamaguchi K., Kyuwa S., Nakanaga K., Hayami M. Establishment of cytotoxic T-cell clones specific for cells infected with mouse hepatitis virus. J Virol. 1988 Jul;62(7):2505–2507. doi: 10.1128/jvi.62.7.2505-2507.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Yasukawa M., Inatsuki A., Kobayashi Y. Helper activity in antigen-specific antibody production mediated by CD4+ human cytotoxic T cell clones directed against herpes simplex virus. J Immunol. 1988 May 15;140(10):3419–3425. [PubMed] [Google Scholar]
  51. Young J. D., Liu C. C. How do cytotoxic T lymphocytes avoid self-lysis? Immunol Today. 1988 Jan;9(1):14–15. doi: 10.1016/0167-5699(88)91349-7. [DOI] [PubMed] [Google Scholar]
  52. Young J. D., Liu C. C., Persechini P. M., Cohn Z. A. Perforin-dependent and -independent pathways of cytotoxicity mediated by lymphocytes. Immunol Rev. 1988 Mar;103:161–202. doi: 10.1111/j.1600-065x.1988.tb00755.x. [DOI] [PubMed] [Google Scholar]
  53. Ziegler H. K., Unanue E. R. Decrease in macrophage antigen catabolism caused by ammonia and chloroquine is associated with inhibition of antigen presentation to T cells. Proc Natl Acad Sci U S A. 1982 Jan;79(1):175–178. doi: 10.1073/pnas.79.1.175. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES